OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+38.3%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$93.2M
AUM Growth
+$93.2M
(-25%)
Cap. Flow
-$35.5M
Cap. Flow
% of AUM
-38.08%
Top 10 Holdings %
Top 10 Hldgs %
96.48%
Holding
23
New
2
Increased
2
Reduced
9
Closed
4
Top Buys
| 1 |
Phathom Pharmaceuticals
PHAT
|
$2.32M |
| 2 |
Myriad Genetics
MYGN
|
$1.47M |
| 3 |
CAVA Group
CAVA
|
$92.8K |
| 4 |
Forian
FORA
|
$795 |
Top Sells
| 1 |
AGEN
Agenus
AGEN
|
$17.6M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$7.1M |
| 3 |
Ardelyx
ARDX
|
$4.09M |
| 4 |
Biohaven
BHVN
|
$3.62M |
| 5 |
EyePoint Pharmaceuticals
EYPT
|
$2M |
Sector Composition
| 1 | Healthcare | 98.15% |
| 2 | Consumer Discretionary | 1.85% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
GeneDx Holdings
WGS
$3.72B
| $28.9M | 26.97% | 1,105,768 -20,839 | -2% | -$545K |
|
|
2
Biohaven
BHVN
$1.63B
| $24.3M | 22.68% | 700,450 -104,400 | -13% | -$3.62M |
|
|
3
Ardelyx
ARDX
$1.53B
| $11M | 10.29% | 1,488,131 -551,569 | -27% | -$4.09M |
|
|
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
| $8.78M | 8.2% | 233,200 -188,383 | -45% | -$7.1M |
|
5
QuidelOrtho
QDEL
$1.95B
| $3.93M | 3.67% | 118,291 -38,910 | -25% | -$1.29M |
|
|
6
Forian
FORA
$61.3M
| $3.59M | 3.35% | 1,356,107 +300 | +0% | +$795 |
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.31M | 3.09% | 535,558 | – | – |
|
|
8
Phathom Pharmaceuticals
PHAT
$864M
| $2.32M | 2.16% | +225,000 | New | +$2.32M |
|
|
9
EyePoint Pharmaceuticals
EYPT
$797M
| $2.02M | 1.88% | 231,857 -230,000 | -50% | -$2M |
|
|
10
CAVA Group
CAVA
$7.83B
| $1.73M | 1.61% | 18,600 +1,000 | +6% | +$92.8K |
|
|
11
Myriad Genetics
MYGN
$593M
| $1.47M | 1.37% | +60,000 | New | +$1.47M |
|
12
Pacific Biosciences
PACB
$393M
| $580K | 0.54% | 423,138 -932,888 | -69% | -$1.28M |
|
13
Biogen
BIIB
$19.4B
| $559K | 0.52% | 2,412 | – | – |
|
|
WBA
14
DELISTED
Walgreens Boots Alliance
WBA
| $333K | 0.31% | 27,500 | – | – |
|
|
AGEN
15
Agenus
AGEN
$133M
| $293K | 0.27% | 17,500 -1,049,463 | -98% | -$17.6M |
|
16
Biodesix
BDSX
$62.6M
| $44.2K | 0.04% | 28,916 -1,435 | -5% | -$2.2K |
|
|
AXDX
17
DELISTED
Accelerate Diagnostics
AXDX
| – | – | -42,101 | Closed | -$41.7K |
|
|
IMMP
18
Immutep
IMMP
$234M
| – | – | -564,879 | Closed | -$1.32M |
|
|
OPTN
19
DELISTED
OptiNose
OPTN
| – | – | -325,000 | Closed | -$475K |
|
20
Palantir
PLTR
$372B
| – | – | 0 | – | – |
|
21
STAAR Surgical
STAA
$1.36B
| – | – | 0 | – | – |
|
22
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
|
DMTK
23
DELISTED
DermTech, Inc. Common Stock
DMTK
| – | – | -47,687 | Closed | -$33.5K |
|